What we've found so far is that the evidence supports guidelines focused on checking and treating high cholesterol, triglycerides, and lipoprotein(a) as part of heart disease prevention [1]. Our analysis of the available research shows this approach is widely backed in the medical literature, with 20.0 supporting assertions and none that refute it [1].
We looked at what the guideline says and found it centers on how healthcare providers should manage abnormal blood fats—specifically high cholesterol, high triglycerides, and elevated lipoprotein(a)—to reduce the risk of heart disease [1]. These blood markers are linked to the buildup of plaque in arteries, which can lead to heart attacks and strokes. The guideline outlines ways to measure them and suggests treatment strategies for people at risk.
Our current analysis shows that managing these blood fats is considered an important part of preventive care. The evidence we've reviewed leans toward routine screening and intervention, especially for people with other risk factors. However, we are only reporting what the evidence says—not making recommendations or judgments about individual care.
It’s important to note that while the support for this guideline is consistent in the data we analyzed, our understanding could evolve as new studies emerge. We don’t yet have data on how well these treatments work for everyone, or which exact thresholds should trigger treatment in all cases.
The takeaway: Checking and managing high cholesterol, triglycerides, and lipoprotein(a) is a common approach doctors use to help lower heart disease risk—and the evidence we’ve reviewed supports this practice [1]. But decisions should be made with a healthcare provider, based on your personal health picture.
2 items of evidenceView full answer